Literature DB >> 17387388

Association of HLA class II allele and haplotype frequencies with chronic myelogenous leukemia and age-at-onset of the disease.

Ali-Akbar Amirzargar1, Farideh Khosravi, Saied S Dianat, Kamran Alimoghadam, Fereidoun Ghavamzadeh, Bita Ansaripour, Batool Moradi, Behrooz Nikbin.   

Abstract

Chronic myelogenous leukemia (CML) is characterized by the presence of Philadelphia chromosome resulting from bcr/abl translocation. To clarify the association between HLA class II allele and haplotype frequencies in CML, 50 patients referred to Hematology Oncology and Bone Marrow Transplantation (BMT) center, Shariaty Hospital, Tehran, Iran, were randomly selected and compared with a group of 80 unrelated healthy blood donor subjects. HLA class II alleles were determined by PCR-SSP method. The results showed that the frequencies of DQB1*03011 (P=0.01) and DQA1*0505 (P=0.05) were higher, while that of DQB1*03032 (P=0.04) was lower in patients than in the controls. Regarding age-at-onset, the frequency of HLA-DRB1*07 (P=0.03) and -DQA1*0201 (P=0.03) alleles were higher in patients younger than 35 years. The most frequent haplotypes in our CML patients were HLA-DRB1*11/-DQB1*03011/-DQA1*0505 (P=0.01) and HLA-DRB1*04/-DQB1*0302/-DQA1*03011 (P=0.02). In conclusion, it is suggested that positive and negative association in certain HLA alleles and haplotypes exist in Iranian patients with CML.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387388     DOI: 10.1007/bf02893440

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  16 in total

1.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

Authors:  O Olerup; H Zetterquist
Journal:  Tissue Antigens       Date:  1992-05

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry.

Authors:  E F Posthuma; J H Falkenburg; J F Apperley; A Gratwohl; B Hertenstein; R F Schipper; M Oudshoorn; J H Biezen; J Hermans; R Willemze; E Roosnek; D Niederwieser
Journal:  Leukemia       Date:  2000-05       Impact factor: 11.528

4.  Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells.

Authors:  G J ten Bosch; A C Toornvliet; T Friede; C J Melief; O C Leeksma
Journal:  Leukemia       Date:  1995-08       Impact factor: 11.528

5.  [Association of HLA-DPB1 alleles with chronic myelogenous leukemia in southern Chinese Hans].

Authors:  Hong Tian; Shu-Yun Zhou; Ze-Huan Liu; Yong-Gui Fu; Feng-Juan Lu; Jiang-Hai Lin; An-Long Xu
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2003-06

6.  BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors.

Authors:  G Pawelec; H Max; T Halder; O Bruserud; A Merl; P da Silva; H Kalbacher
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

7.  HLA associations with leukemia.

Authors:  M M Bortin; J D'Amaro; F H Bach; A A Rimm; J J van Rood
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

8.  HLA system affects the age-at-onset in chronic myeloid leukemia.

Authors:  Fatma Savran Oguz; Sevgi Kalayoglu; A Sarper Diler; Hilmi Tozkir; Deniz Sargin; Mahmut Carin; M Tevfik Dorak
Journal:  Am J Hematol       Date:  2003-08       Impact factor: 10.047

Review 9.  Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics.

Authors:  Razelle Kurzrock; Hagop M Kantarjian; Brian J Druker; Moshe Talpaz
Journal:  Ann Intern Med       Date:  2003-05-20       Impact factor: 25.391

10.  Human major histocompatibility complex contains several leukemia susceptibility genes.

Authors:  M T Dorak; E A Chalmers; D Gaffney; D W Wilson; I Galbraith; N Henderson; M Worwood; K I Mills; A K Burnett
Journal:  Leuk Lymphoma       Date:  1994-01
View more
  6 in total

1.  HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer.

Authors:  Majid Mahmoodi; Hedayat Nahvi; Mahdi Mahmoudi; Amir Kasaian; Mohammad-Ali Mohagheghi; Kouros Divsalar; Bijan Nahavandian; Abbas Jafari; Bita Ansarpour; Batoul Moradi; Asghar Aghamohammadi; Aliakbar Amirzargar
Journal:  Pathol Oncol Res       Date:  2011-07-01       Impact factor: 3.201

2.  Association between HLA-DQB1 gene and patients with acute lymphoblastic leukemia (ALL).

Authors:  Elias Orouji; Jalil Tavakkol Afshari; Zahra Badiee; Abbas Shirdel; Afrouz Alipour
Journal:  Int J Hematol       Date:  2012-03-21       Impact factor: 2.490

3.  Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.

Authors:  Sally N Adebamowo; Adebowale A Adeyemo
Journal:  Hum Immunol       Date:  2019-05-06       Impact factor: 2.850

4.  Human leukocyte antigen-DRB1 polymorphism in childhood acute lymphoblastic leukemia.

Authors:  Mervat M El Ansary; Lamiaa A Mohammed; Tamer H Hassan; Ahmed Baraka; Alshymaa A Ahmed
Journal:  Mol Clin Oncol       Date:  2014-11-25

5.  High-Resolution HLA-A Typing in Normal Iranian Population

Authors:  Azadeh Hadadianpour; Mohammad Hasan Samiee Aref; Sirous Zeinali
Journal:  Iran Biomed J       Date:  2017-09-27

Review 6.  Genetics of blood malignancies among Iranian population: an overview.

Authors:  Majid Ghayour-Mobarhan; Amir Sadra Zangouei; Seyed Mohammad Hosseinirad; Majid Mojarrad; Meysam Moghbeli
Journal:  Diagn Pathol       Date:  2020-05-06       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.